Frequent CTLA4-CD28 gene fusion in diverse types of T-cell lymphoma

Haematologica

Volumn 101, Issue 6, 2016, Pages 757-763

  Yoo, Hae Yong ^a,b   Kim, Pora ^c   Kim, Won Seog ^b,d   Lee, Seung Ho ^a   Kim, Sangok ^c   Kang, So Young ^d   Jang, Hye Yoon ^e   Lee, Jong Eun ^e   Kim, Jaesang ^c   Kim, Seok Jin ^b,d   Ko, Young Hyeh ^b,d   Lee, Sanghyuk ^c  

^a Sungkyunkwan University   (South Korea)

^b Samsung Medical Center   (South Korea)

^c Ewha Womans University   (South Korea)

^d Sungkyunkwan University School of Medicine   (South Korea)

^e DNA Link Inc   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CD28 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; INTERLEUKIN 2; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN KINASE B; TRANSCRIPTION FACTOR 7 LIKE 1; CYTOKINE; ONCOPROTEIN;

ANGIOIMMUNOBLASTIC T CELL LYMPHOMA; ARTICLE; B CELL LYMPHOMA; BIOINFORMATICS; CANCER IMMUNOTHERAPY; CELL PROLIFERATION; ECTOPIC EXPRESSION; ENZYME LINKED IMMUNOSORBENT ASSAY; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; GENE EXPRESSION; GENE FREQUENCY; GENE FUNCTION; GENE FUSION; GENE SEQUENCE; GENETIC TRANSFECTION; HELPER CELL; HUMAN; HUMAN CELL; JURKAT CELL LINE; MOLECULARLY TARGETED THERAPY; PERIPHERAL T CELL LYMPHOMA; PHENOTYPE; PHOSPHORYLATION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA SEQUENCE; T CELL LYMPHOMA; T LYMPHOCYTE ACTIVATION; BIOLOGY; GENE DOSAGE; GENE EXPRESSION PROFILING; GENE ORDER; GENETIC ASSOCIATION STUDY; GENETICS; HIGH THROUGHPUT SEQUENCING; METABOLISM; MUTATION; PATHOLOGY; PROCEDURES; REPRODUCIBILITY; TUMOR CELL LINE;

ANTIGENS, CD28; CELL LINE, TUMOR; CELL PROLIFERATION; COMPUTATIONAL BIOLOGY; CTLA-4 ANTIGEN; CYTOKINES; GENE DOSAGE; GENE EXPRESSION PROFILING; GENE ORDER; GENETIC ASSOCIATION STUDIES; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; LYMPHOMA, T-CELL; MUTATION; ONCOGENE PROTEINS, FUSION; PHENOTYPE; REPRODUCIBILITY OF RESULTS;

EID: 84971572279     PISSN: 03906078     EISSN: 15928721     Source Type: Journal    
DOI: 10.3324/haematol.2015.139253     Document Type: Article

References (27)

1. Cairns RA, Iqbal J, Lemonnier F, et al. IDH2 mutations are frequent in angioimmunoblastic T-cell lymphoma. Blood. 2012;119(8):1901-1903.
2. Lemonnier F, Couronné L, Parrens M, et al. Recurrent TET2 mutations in peripheral Tcell lymphomas correlate with TFH-like features and adverse clinical parameters. Blood. 2012;120(7):1466-1469.
3. Palomero T, Couronné L, Khiabanian H, et al. Recurrent mutations in epigenetic regulators, RHOA and FYN kinase in peripheral T cell lymphomas. Nat Genet. 2014;46(2):166-170.
4. Sakata-Yanagimoto M, Enami T, Yoshida K, et al. Somatic RHOA mutation in angioimmunoblastic T cell lymphoma. Nat Genet. 2014;46(2):171-175.
5. Yoo HY, Sung MK, Lee SH, et al. A recurrent inactivating mutation in RHOA GTPase in angioimmunoblastic T cell lymphoma. Nat Genet. 2014;46(4):371-375.
6. Rudd CE, Taylor A, Schneider H. CD28 and CTLA-4 coreceptor expression and signal transduction. Immunol Rev. 2009;229 (1):12-26.
7. Kuehn HS, Ouyang W, Lo B, et al. Immune dysregulation in human subjects with heterozygous germline mutations in CTLA4. Science. 2014;345(6204):162316-162327.
8. Leach DR, Krummel MF, Allison JP. Enhancement of antitumor immunity by CTLA-4 blockade. Science. 1996;271(5256): 1734-1736.
9. Hodi FS, O'Day SJ, McDermott DF, et al. Improved survival with ipilimumab in patients with metastatic melanoma. N Engl J Med. 2010;363(8):711-723.
10. Johnson LA, Morgan RA, Dudley ME, et al. Gene therapy with human and mouse T-cell receptors mediates cancer regression and targets normal tissues expressing cognate antigen. Blood. 2009;114(3):535-546.
11. Gunawardana J, Gunawardana J, Chan FC, et al. Recurrent somatic mutations of PTPN1 in primary mediastinal B cell lymphoma and Hodgkin lymphoma. Nat Genet. 2014;46(4): 329-335.
12. Lohr JG, Stojanov P, Lawrence MS, et al. Discovery and prioritization of somatic mutations in diffuse large B-cell lymphoma (DLBCL) by whole-exome sequencing. Proc Natl Acad Sci USA 2012;109(10):3879-3884.
13. Okosun J, Bödör C, Wang J, et al. Integrated genomic analysis identifies recurrent mutations and evolution patterns driving the initiation and progression of follicular lymphoma. Nat Genet. 2014;46(2):176-181.
14. Richter J, Schlesner M, Hoffmann S, et al. Recurrent mutation of the ID3 gene in Burkitt lymphoma identified by integrated genome, exome and transcriptome sequencing. Nat Genet. 2012;44(12):1316-1320.
15. Schmitz R, Young RM, Ceribelli M, et al. Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics. Nature. 2012;490(7418):116-120.
16. Zhang J, Grubor V, Love CL, et al. Genetic heterogeneity of diffuse large B-cell lymphoma. Proc Natl Acad Sci USA. 2013; 110(4):1398-1403.
17. Love C, Sun Z, Jima D, et al. The genetic landscape of mutations in Burkitt lymphoma. Nat Genet. 2012;44(12):1321-1325.
18. Couronné L, Bastard C, Bernard OA. TET2 and DNMT3A mutations in human T-cell lymphoma. N Engl J Med. 2012;366(1):95-96.
19. Shin JH, Park HB, Oh YM, et al. Positive conversion of negative signaling of CTLA4 potentiates antitumor efficacy of adoptive Tcell therapy in murine tumor models. Blood. 2012;119(24):5678-5687.
20. Graux C, Cools J, Melotte C, et al. Fusion of NUP214 to ABL1 on amplified episomes in T-cell acute lymphoblastic leukemia. Nat Genet. 2004;36(10):1084-1089.
21. Genovese G, Kähler AK, Handsaker RE, et al. Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence. N Engl J Med. 2014;371(26):2477-2487.
22. Jaiswal S, Fontanillas P, Flannick J, et al. Agerelated clonal hematopoiesis associated with adverse outcomes. N Engl J Med. 2014;371 (26):2488-2498.
23. Xie M, Lu C, Wang J, et al. Age-related mutations associated with clonal hematopoietic expansion and malignancies. Nat Med. 2014;20(12):1472-1478.
24. Lee SH, Kim JS, Kim J, et al. A highly recurrent novel missense mutation in CD28 among angioimmunoblastic T-cell lymphoma patients. Haematologica. 2015;100 (12):e505-507.
25. Sekulic A, Liang WS, Tembe W, et al. Personalized treatment of Sezary syndrome by targeting a novel CTLA4:CD28 fusion. Mol Genet Genomic Med. 2015;3(2):130-136.
26. Ungewickell A, Bhaduri A, Rios E, et al. Genomic analysis of mycosis fungoides and Sezary syndrome identifies recurrent alterations in TNFR2. Nat Genet. 2015;47(9): 1056-1060.
27. Correia C, Schneider PA, Dai H, et al. BCL2 mutations are associated with increased risk of transformation and shortened survival in follicular lymphoma. Blood. 2015;125(4): 658-667.